Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
hydromorphone delta-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.96 approved,illicit partial agonist
hydromorphone opioid receptor delta NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.96 approved agonist
hydromorphone opioid receptor delta NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.96 approved unknown
hydromorphone delta-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 1.96 approved,illicit partial agonist,agonist
hydromorphone kappa-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.86 approved,illicit agonist
hydromorphone mu-type opioid receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.72 approved,illicit agonist
hydromorphone opioid receptor mu NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.72 approved unknown
hydromorphone opioid receptor mu NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Acute onset pain[MeSHID:D059787]
Addictive Behavior[MeSHID:D016739]
Drug Overdose[MeSHID:D062787]
Coughing[MeSHID:D003371]
Pain[MeSHID:D010146]
Chronic pain[MeSHID:D059350]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.72 approved agonist
click here to return to the previous page